Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
5.40
+0.13 (2.47%)
At close: Oct 31, 2024, 4:00 PM
5.51
+0.11 (2.04%)
After-hours: Oct 31, 2024, 7:01 PM EDT
Amylyx Pharmaceuticals Employees
Amylyx Pharmaceuticals had 384 employees as of December 31, 2023. The number of employees increased by 122 or 46.56% compared to the previous year.
Employees
384
Change (1Y)
122
Growth (1Y)
46.56%
Revenue / Employee
$778,026
Profits / Employee
-$431,951
Market Cap
367.65M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 384 | 122 | 46.56% |
Dec 31, 2022 | 262 | 57 | 27.80% |
Dec 31, 2021 | 205 | 171 | 502.94% |
Dec 31, 2020 | 34 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Enhabit | 10,800 |
DocGo | 4,164 |
ZimVie | 2,600 |
Viemed Healthcare | 996 |
Anika Therapeutics | 357 |
Alpha Teknova | 211 |
Voyager Therapeutics | 162 |
Nyxoah | 147 |
AMLX News
- 14 days ago - Amylyx Pharmaceuticals Announces Positive Topline Results from Phase 2 HELIOS Clinical Trial Demonstrating Sustained Improvements with AMX0035 in People Living with Wolfram Syndrome - Business Wire
- 16 days ago - Amylyx Pharmaceuticals to Host Virtual Webcast to Discuss Topline Results from Phase 2 HELIOS Study of AMX0035 in Wolfram Syndrome on October 17, 2024 - Business Wire
- 4 weeks ago - Kuehn Law Encourages Investors of Amylyx Pharmaceuticals, Inc. to Contact Law Firm - PRNewsWire
- 2 months ago - Amylyx Pharmaceuticals to Participate in Upcoming Investor Conferences - Business Wire
- 2 months ago - Amylyx Pharmaceuticals Announces Publication of Data Showing the Encouraging Effects of AMX0035 on Cerebrospinal Fluid Biomarkers of Core Alzheimer's Disease Pathology and Neurodegeneration - Business Wire
- 2 months ago - Amylyx Pharmaceuticals, Inc. (AMLX) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Amylyx Pharmaceuticals Reports Second Quarter 2024 Financial Results - Business Wire
- 3 months ago - Amylyx Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 8, 2024 - Business Wire